These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24493670)

  • 1. Tracing the development of acute myeloid leukemia in CBL syndrome.
    Becker H; Yoshida K; Blagitko-Dorfs N; Claus R; Pantic M; Abdelkarim M; Niemöller C; Greil C; Hackanson B; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Döhner K; Schnittger S; Henneke P; Niemeyer CM; Flotho C; Pfeifer D; Ogawa S; Lübbert M
    Blood; 2014 Mar; 123(12):1883-6. PubMed ID: 24493670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single cell genotyping of exome sequencing-identified mutations to characterize the clonal composition and evolution of inv(16) AML in a CBL mutated clonal hematopoiesis.
    Niemöller C; Renz N; Bleul S; Blagitko-Dorfs N; Greil C; Yoshida K; Pfeifer D; Follo M; Duyster J; Claus R; Ogawa S; Lübbert M; Becker H
    Leuk Res; 2016 Aug; 47():41-6. PubMed ID: 27244256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CBL exon 8/9 mutants activate the FLT3 pathway and cluster in core binding factor/11q deletion acute myeloid leukemia/myelodysplastic syndrome subtypes.
    Reindl C; Quentmeier H; Petropoulos K; Greif PA; Benthaus T; Argiropoulos B; Mellert G; Vempati S; Duyster J; Buske C; Bohlander SK; Humphries KR; Hiddemann W; Spiekermann K
    Clin Cancer Res; 2009 Apr; 15(7):2238-47. PubMed ID: 19276253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult-onset acute myeloid leukaemia in a patient with germline mutation of CBL.
    Ali AM; Cooper J; Walker A; Jones D; Saad A
    Br J Haematol; 2021 Feb; 192(3):665-667. PubMed ID: 33216958
    [No Abstract]   [Full Text] [Related]  

  • 5. CBL mutation in chronic myelomonocytic leukemia secondary to familial platelet disorder with propensity to develop acute myeloid leukemia (FPD/AML).
    Shiba N; Hasegawa D; Park MJ; Murata C; Sato-Otsubo A; Ogawa C; Manabe A; Arakawa H; Ogawa S; Hayashi Y
    Blood; 2012 Mar; 119(11):2612-4. PubMed ID: 22138511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex patterns of chromosome 11 aberrations in myeloid malignancies target CBL, MLL, DDB1 and LMO2.
    Klampfl T; Milosevic JD; Puda A; Schönegger A; Bagienski K; Berg T; Harutyunyan AS; Gisslinger B; Rumi E; Malcovati L; Pietra D; Elena C; Della Porta MG; Pieri L; Guglielmelli P; Bock C; Doubek M; Dvorakova D; Suvajdzic N; Tomin D; Tosic N; Racil Z; Steurer M; Pavlovic S; Vannucchi AM; Cazzola M; Gisslinger H; Kralovics R
    PLoS One; 2013; 8(10):e77819. PubMed ID: 24147083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline CBL mutation associated with a noonan-like syndrome with primary lymphedema and teratoma associated with acquired uniparental isodisomy of chromosome 11q23.
    Hanson HL; Wilson MJ; Short JP; Chioza BA; Crosby AH; Nash RM; Marks KJ; Mansour S
    Am J Med Genet A; 2014 Apr; 164A(4):1003-9. PubMed ID: 24458550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal selection of 11q CN-LOH and CBL gene mutation in a serially studied patient during MDS progression to AML.
    Barresi V; Palumbo GA; Musso N; Consoli C; Capizzi C; Meli CR; Romano A; Di Raimondo F; Condorelli DF
    Leuk Res; 2010 Nov; 34(11):1539-42. PubMed ID: 20674974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of c-Cbl mutations in human acute myeloid leukaemias in an Australian patient cohort.
    Ghassemifar R; Thien CB; Finlayson J; Joske D; Cull GM; Augustson B; Langdon WY
    Pathology; 2011 Apr; 43(3):261-5. PubMed ID: 21436637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia.
    Pérez B; Mechinaud F; Galambrun C; Ben Romdhane N; Isidor B; Philip N; Derain-Court J; Cassinat B; Lachenaud J; Kaltenbach S; Salmon A; Désirée C; Pereira S; Menot ML; Royer N; Fenneteau O; Baruchel A; Chomienne C; Verloes A; Cavé H
    J Med Genet; 2010 Oct; 47(10):686-91. PubMed ID: 20543203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile myelomonocytic leukemia due to a germline CBL Y371C mutation: 35-year follow-up of a large family.
    Pathak A; Pemov A; McMaster ML; Dewan R; Ravichandran S; Pak E; Dutra A; Lee HJ; Vogt A; Zhang X; Yeager M; Anderson S; Kirby M; ; ; Caporaso N; Greene MH; Goldin LR; Stewart DR
    Hum Genet; 2015 Jul; 134(7):775-87. PubMed ID: 25939664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies.
    Bacher U; Haferlach C; Schnittger S; Kohlmann A; Kern W; Haferlach T
    Ann Hematol; 2010 Jul; 89(7):643-52. PubMed ID: 20195608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of splenomegaly in CBL syndrome.
    Coe RR; McKinnon ML; Tarailo-Graovac M; Ross CJ; Wasserman WW; Friedman JM; Rogers PC; van Karnebeek CDM
    Eur J Med Genet; 2017 Jul; 60(7):374-379. PubMed ID: 28414188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of CBL, a proto-oncogene at 11q23.3, as a novel MLL fusion partner in a patient with de novo acute myeloid leukemia.
    Fu JF; Hsu JJ; Tang TC; Shih LY
    Genes Chromosomes Cancer; 2003 Jun; 37(2):214-9. PubMed ID: 12696071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.
    Sanada M; Suzuki T; Shih LY; Otsu M; Kato M; Yamazaki S; Tamura A; Honda H; Sakata-Yanagimoto M; Kumano K; Oda H; Yamagata T; Takita J; Gotoh N; Nakazaki K; Kawamata N; Onodera M; Nobuyoshi M; Hayashi Y; Harada H; Kurokawa M; Chiba S; Mori H; Ozawa K; Omine M; Hirai H; Nakauchi H; Koeffler HP; Ogawa S
    Nature; 2009 Aug; 460(7257):904-8. PubMed ID: 19620960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.
    Makishima H; Cazzolli H; Szpurka H; Dunbar A; Tiu R; Huh J; Muramatsu H; O'Keefe C; Hsi E; Paquette RL; Kojima S; List AF; Sekeres MA; McDevitt MA; Maciejewski JP
    J Clin Oncol; 2009 Dec; 27(36):6109-16. PubMed ID: 19901108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In hematopoietic cells with a germline mutation of CBL, loss of heterozygosity is not a signature of juvenile myelo-monocytic leukemia.
    Strullu M; Caye A; Cassinat B; Fenneteau O; Touzot F; Blauwblomme T; Rodriguez R; Latour S; Petit A; Barlogis V; Galambrun C; Leblanc T; Baruchel A; Chomienne C; Cavé H
    Leukemia; 2013 Dec; 27(12):2404-7. PubMed ID: 23823657
    [No Abstract]   [Full Text] [Related]  

  • 18. CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.
    Lv K; Jiang J; Donaghy R; Riling CR; Cheng Y; Chandra V; Rozenova K; An W; Mohapatra BC; Goetz BT; Pillai V; Han X; Todd EA; Jeschke GR; Langdon WY; Kumar S; Hexner EO; Band H; Tong W
    Genes Dev; 2017 May; 31(10):1007-1023. PubMed ID: 28611190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO.
    Goyama S; Schibler J; Gasilina A; Shrestha M; Lin S; Link KA; Chen J; Whitman SP; Bloomfield CD; Nicolet D; Assi SA; Ptasinska A; Heidenreich O; Bonifer C; Kitamura T; Nassar NN; Mulloy JC
    Leukemia; 2016 Mar; 30(3):728-39. PubMed ID: 26449661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in CBL occur frequently in juvenile myelomonocytic leukemia.
    Loh ML; Sakai DS; Flotho C; Kang M; Fliegauf M; Archambeault S; Mullighan CG; Chen L; Bergstraesser E; Bueso-Ramos CE; Emanuel PD; Hasle H; Issa JP; van den Heuvel-Eibrink MM; Locatelli F; Stary J; Trebo M; Wlodarski M; Zecca M; Shannon KM; Niemeyer CM
    Blood; 2009 Aug; 114(9):1859-63. PubMed ID: 19571318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.